T.J.H. Arends
Papers
2
Total Citations
10
H-Index
2
About
T.J.H. Arends is a leading surgical oncologist whose research centers on improving outcomes for patients with bladder cancer, particularly through the comparative evaluation of robotic and open surgical techniques. His major contributions lie in the rigorous assessment of robot-assisted radical cystectomy (RARC) versus the traditional open approach for muscle-invasive and high-risk non-muscle invasive bladder cancer. Arends’ landmark 2021 study, cited 8 times, provided critical intermediate-term survival data from The Netherlands, demonstrating that RARC offers non-inferior oncological outcomes compared to open surgery, thereby supporting the broader adoption of minimally invasive techniques without compromising patient survival. His subsequent work, with 2 citations, further validated these findings, reinforcing the safety and efficacy of robotic surgery in this challenging patient population. By delivering real-world evidence from a national cohort, Arends has helped shape clinical guidelines and surgical decision-making, offering patients a less invasive option with comparable long-term results. His research is essential reading for urologists and oncologists seeking to balance technological innovation with proven oncologic principles.
Research Focus
Key Achievements
Top Papers
- 1
- 2